Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure

NCT ID: NCT06780722

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-19

Study Completion Date

2027-06-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the level of hypoxemia during the occurrence of cardiocirculatory arrest during a Maastricht III organ donation procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation of the level of hypoxemia during the occurrence of cardiocirculatory arrest during a Maastricht III organ donation procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest Reanimation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sampling

* The first sample is taken at the start of the therapeutic stop.
* The second sample is taken when the mean arterial pressure drops to 45mmHg.
* The third sample is taken when circulatory arrest occurs.
* The fourth sample is taken at the start of extracorporeal circulation. These four samples will be destroyed at the end of the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years of age
* Organ donation procedure initiated in accordance with the legislation and procedures in force in France for the Maastricht III category
* No opposition formulated by the relative to the patient's participation in the study


* No opposition to the collection of data concerning him/her
* Patient over 18 at pre-transplant consultation
* Patient who has received an organ from a donor participating in the HEPHAISTOS protocol

Exclusion Criteria

* Patient registered on the national register of refusals or living refusal of donation
* Pregnant or breast-feeding women
* Patients under guardianship, curatorship or legal protection
* Medical contraindication to organ donation according to the recommendations of the Agence de Biomédecine currently in force in France

FOR THE RECEIVER


\- Patients under guardianship, curatorship or legal protection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU ANGERS - Réanimation médicale

Angers, , France

Site Status NOT_YET_RECRUITING

CHU ANGERS - Urgences - Coordination Prélèvements

Angers, , France

Site Status NOT_YET_RECRUITING

CH ANNECY GENEVOIS - Réanimation médicale - Coordination Prélèvements multi-organes

Annecy, , France

Site Status NOT_YET_RECRUITING

CH AVIGNON - CH Henri Duffaut - Réanimation polyvalente

Avignon, , France

Site Status NOT_YET_RECRUITING

CHD Vendée - Les Oudairies - Médecine Intensive Réanimation -Coordination Prélèvements multi-organes

La Roche-sur-Yon, , France

Site Status NOT_YET_RECRUITING

CHD Vendée - Les Oudairies - Médecine Intensive Réanimation

La Roche-sur-Yon, , France

Site Status NOT_YET_RECRUITING

CHU LILLE - Hôpital Roger Salengro - Coordination prélèvements multi-organes

Lille, , France

Site Status NOT_YET_RECRUITING

CHU LILLE - Hôpital Roger Salengro - Médecine Intensive Réanimation

Lille, , France

Site Status NOT_YET_RECRUITING

CHU NANTES +- Médecine Intensive Réanimation

Nantes, , France

Site Status NOT_YET_RECRUITING

CHU Nantes - Coordination prélèvement multi organes

Nantes, , France

Site Status RECRUITING

CHRU ORLEANS -Médecine Intensive Réanimation - Coordination Prélèvements multi-organes

Orléans, , France

Site Status NOT_YET_RECRUITING

APHP Hôpital COCHIN - Coordination Prélèvements d'Organes et Tissus

Paris, , France

Site Status NOT_YET_RECRUITING

APHP Hôpital COCHIN - Médecine Intensive Réanimation

Paris, , France

Site Status NOT_YET_RECRUITING

CH PERIGUEUX - Réanimation - Coordination Prélèvements Organes et Tissus

Périgueux, , France

Site Status NOT_YET_RECRUITING

CHU POITIERS - Anesthésie Réanimation - Coordination Prélèvements multi-organes

Poitiers, , France

Site Status NOT_YET_RECRUITING

CHU RENNES - CHU Pontchaillou - Réanimation médicale

Rennes, , France

Site Status NOT_YET_RECRUITING

CHRU TOURS - Hôpital Bretonneau - Coordination Prélèvements multi-organes

Tours, , France

Site Status NOT_YET_RECRUITING

CHRU TOURS - Hôpital Bretonneau - Médecine Intensive Réanimation

Tours, , France

Site Status RECRUITING

CHBA Vannes-Auray - Réanimation Polyvalente

Vannes, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean Baptiste LASCARROU

Role: CONTACT

02 40 08 73 76 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mathieu CONTE

Role: primary

02 41 35 38 15 ext. +33

Aurore ARMAND

Role: primary

02 41 35 36 37 ext. +33

Didier DOREZ

Role: primary

04 50 63 65 60 ext. +33

Gael PRADEL

Role: primary

04 32 75 34 61 ext. +33

Laurent MARTIN-LEFEVRE

Role: primary

02 51 44 62 12 ext. +33

Marie-Ange AZAIS

Role: primary

02 51 44 62 12 ext. +33

Erika PARMENTIER

Role: primary

03 20 44 40 84 ext. +33

Côme BUREAU

Role: primary

03 20 44 40 84 ext. +33

Jean-Baptiste LASCARROU

Role: primary

02 40 08 73 86 ext. +33

Laurent MARTIN LEFEVRE

Role: primary

02 44 76 82 05 ext. +33

Anne BRETAGNOL

Role: primary

02 38 51 44 44 ext. +33

Julien CHARPENTIER

Role: primary

01 58 41 25 17 ext. +33

Maxime TOURON

Role: primary

01 58 41 41 49 ext. +33

Edouard SOUM

Role: primary

05 53 45 28 71 ext. +33

Thomas KERFORNE

Role: primary

05 49 44 46 35 ext. +33

Sonia ISSLAME

Role: primary

02 99 28 42 46 ext. +33

Brice FERMIER

Role: primary

02 47 47 37 18 ext. +33

Jean-Christophe VENHARD

Role: primary

02 18 37 08 37 ext. +33

Angélique GOEPP

Role: primary

02 97 01 43 07 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC22_0498

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.